Keith R. Edwards

Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

Nikolaos A. Patsopoulos, Sergio E. Baranzini, Adam Santaniello et al. · Science · 2019 · 1.3K citations · Full text

Immunology, Extended Mhc, Innate Immunity +16

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

Andrew Goodman, Theodore R. Brown, Keith R. Edwards et al. · Annals of Neurology · 2010 · 371 citations

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

Disease Progression, Neurological Disorder, Immunology +8

Cognitive Function in Patients With Multiple Sclerosis

Janis M. Peyser, Keith R. Edwards, Charles M. Poser et al. · Archives of Neurology · 1980 · 241 citations

Neuropsychology, Neurological Disorder, White Matter +16

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Diego Cadavid, Michelle Mellion, Raymond Hupperts et al. · The Lancet Neurology · 2019 · 173 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +5